Sanbio Company Limited Stock Today
| SNBIF Stock | USD 3.85 0.00 0.00% |
Performance0 of 100
| Odds Of DistressOver 55
|
SanBio Company is trading at 3.85 as of the 2nd of December 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 3.85. SanBio Company has over 55 % chance of experiencing financial distress in the next 2 years of operation and has generated negative returns for investors over the last 90 days. Equity ratings for SanBio Company Limited are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 2nd of November 2024 and ending today, the 2nd of December 2024. Click here to learn more.
SanBio Company Limited develops, produces, and sells regenerative cell medicines for the central nervous system. The company was founded in 2001 and is headquartered in Tokyo, Japan. Sanbio is traded on OTC Exchange in the United States. The company has 61.51 M outstanding shares. More on SanBio Company Limited
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
SanBio OTC Stock Highlights
| Chairman and Executive Officer | Toru Kawanishi |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
SanBio Company Limited [SNBIF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Small-Cap' category with a current market capitalization of 338.28 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate SanBio Company's market, we take the total number of its shares issued and multiply it by SanBio Company's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. SanBio Limited classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 61.51 M outstanding shares.
SanBio Company Limited has accumulated about 8.34 B in cash with (6.55 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 139.84, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check SanBio Company Probability Of Bankruptcy
Ownership AllocationSanBio Limited shows a total of 61.51 Million outstanding shares. SanBio Limited maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check SanBio Ownership Details
SanBio Stock Against Markets
Picking the right benchmark for SanBio Company otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in SanBio Company otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for SanBio Company is critical whether you are bullish or bearish towards SanBio Company Limited at a given time. Please also check how SanBio Company's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in SanBio Company without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Fundamental Analysis Now
Fundamental AnalysisView fundamental data based on most recent published financial statements |
| All Next | Launch Module |
SanBio Company Corporate Management
Elected by the shareholders, the SanBio Company's board of directors comprises two types of representatives: SanBio Company inside directors who are chosen from within the company, and outside directors, selected externally and held independent of SanBio. The board's role is to monitor SanBio Company's management team and ensure that shareholders' interests are well served. SanBio Company's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, SanBio Company's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Greg Gillas | Sr Services | Profile | |
| Michael McGrogan | VP Devel | Profile | |
| Kazumi Sawaguchi | Co Japan | Profile | |
| Andrew Liu | Co Officer | Profile | |
| Yoshihiro Kakutani | Co Admin | Profile |
Other Information on Investing in SanBio OTC Stock
SanBio Company financial ratios help investors to determine whether SanBio OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in SanBio with respect to the benefits of owning SanBio Company security.